Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE. Methods A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li-definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death. Results The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8-36.9) cases per million inhabitants. The incidence was highest in men aged 75-79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies [6][7][8] suggest that the risk of neurological deterioration during cardiac surgery after a stroke is lower than previously assumed, particularly in patients with silent cerebrovascular emboli.”
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“residence, dates of first symptoms and first hospitalization, transfer from/to another facility, history of heart disease, comorbidities (including diabetes mellitus, cancer, dialysis, and immunosuppressive therapy), Charlson comorbidity index [13], procedures and other risk factors for IE, signs and symptoms of IE, e…”
BackgroundBurden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundProposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027 · cited 1×
“This process also included the validation of the diagnosis according to the Duke criteria modified by Li [20].”
MethodIung, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00201-x · Cited by 3,530 · cited 2×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundSelf-citationMurdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362 · cited 3×
“pathogens in cases of IE [9]; these findings were later confirmed by different observational studies [1, 6].”
BackgroundResultSelf-citationFriedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668 · cited 1×
“The mode of IE acquisition was categorized on the basis of 3 mutually exclusive classes: (1) injection drug use–associated IE, (2) community-acquired IE, and (3) healthcare-associated IE, which included nosocomial and nonnosocomial IE, according to prior definitions [6, 14–16] described in detail in the supplementary…”
MethodStaphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174 · cited 6×
“aureus IE study by Fowler et al [6].”
BackgroundMethodResultInfluentialSelf-citationJarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., Nesme, X., Etienne, J., & Vandenesch, F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.631-641.2002 · Cited by 1,151 · cited 1×
“Microbiologists were asked to send all strains of streptococci and staphylococci to the corresponding national reference centers, where identification was confirmed on the basis of phenotypic and molecular microbiology techniques [17–19].”
BackgroundSelf-citationChanging Profile of Infective Endocarditis<SUBTITLE>Results of a 1-Year Survey in France</SUBTITLE>
Hoen, B. (2002) · JAMA · doi:10.1001/jama.288.1.75 · Cited by 987
Self-citationMoreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Research works printed but not linked: 1
- 2002, Changing profile of infective endocarditis: results of a one-year survey in France in 1999, JAMA, 288, 75
Cited by
Items 101–200 of 790
Impact of Setting up an “Endocarditis Team” on the Management of Infective Endocarditis
Ruch, Y., Mazzucotelli, J., Lefebvre, F., Martin, A., Lefèbvre, N., Douiri, N., Riegel, P., Minh, T. H., Petit‐Eisenmann, H., Hansmann, Y., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz308 · Cited by 54
“Despite the constant evolution of antibiotic regimens, the prognosis of IE remains poor, with in-hospital mortality ranging from 15% to 22% [3, 4].”
BackgroundResultGuía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J., Zotti, F. D., Dulgheru, R., Khoury, G. A. E., Erba, P. A., Iung, B., et al. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.11.015 · Cited by 54
Self-citationClinical and economic outcomes of infective endocarditis
Sunder, S., Grammatico‐Guillon, L., Baron, S., Gaborit, C., Bernard, A. B., Garot, D., Legras, A., Prazuck, T., Dibon, O., Boulain, T., et al. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.968608 · Cited by 54
Mori, M., Brown, K. J., Mahmood, S. U. B., Geirsson, A., & Mangi, A. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.012465 · Cited by 53
Forestier, E., Baudron, C. R., Fraisse, T., Patry, C., Gavazzi, G., Hoen, B., Caraux-Paz, P., Moheb-Khosravi, B., Delahaye, F., Sost, G., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.021 · Cited by 53
Self-citationFernández‐Hidalgo, N., Ribera, A., Larrosa, N., Viedma, E., Origüen, J., de Alarcón, A., Fariñas, M. C., Sáez, C., Peña, C., Múñez, E., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.002 · Cited by 52
Endocardite Infecciosa: Ainda mais Desafios que Certezas
Sousa, C., & Pinto, F. J. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200798 · Cited by 52
Early surgical therapy of infective endocarditis in children: A 15-year experience
Shamszad, P., Khan, M. S., Rossano, J. W., & Fraser, C. D. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.12.001 · Cited by 52
Infectious endocarditis: An update for emergency clinicians
Long, B., & Koyfman, A. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.06.074 · Cited by 51
“NIE occurs after 48 h of hospitalization or is associated with a healthcare environment within 4 weeks of a performed procedure [13, 25, 26, 28, 36, 37].”
BackgroundInfluentialS. aureus endocarditis: Clinical aspects and experimental approaches
Hoerr, V., Franz, M., Pletz, M. W., Diab, M., Niemann, S., Faber, C., Doenst, T., Schulze, P. C., Deinhardt‐Emmer, S., & Löffler, B. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.02.004 · Cited by 51
Chan, L. C., Chaili, S., Filler, S. G., Miller, L. S., Solis, N. V., Wang, H., Johnson, C. W., Lee, H. K., Diaz, L. F., & Yeaman, M. R. (2017) · Infection and Immunity · doi:10.1128/iai.00876-16 · Cited by 51
“The public health impact of this trend is of urgent concern, especially given the 15 to 40% mortality rate associated with invasive MRSA infection (25, 26).”
BackgroundInfective Endocarditis in Low- and Middle-Income Countries
Njuguna, B., Gardner, A. F., Karwa, R., & Delahaye, F. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2016.08.011 · Cited by 50
“A total of 52% of the total patient cohort received surgical intervention, closely approximating the rate seen in HICs.(2) DVD contributes little to the IE epidemiology in LMICs, accounting for less than 10% of cases.”
BackgroundResultInfluentialSelf-citationYang, E., & Frazee, B. W. (2018) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2018.06.002 · Cited by 50
Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus
Bergin, S. P., Holland, T. L., Fowler, V. G., & Tong, S. Y. C. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5001 · Cited by 50
Mitral endocarditis: A new management framework
Nappi, F., Spadaccio, C., Dreyfus, J., Attias, D., Acar, C., & Bando, K. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.03.159 · Cited by 50
Infectious Diseases of the Heart: Pathophysiology, Clinical and Imaging Overview
Murillo, H., Restrepo, C. S., Marmol-Velez, A., Vargas, D., Ocazionez, D., Martínez-Jiménez, S., Reddick, R. L., & Baxi, A. J. (2016) · Radiographics · doi:10.1148/rg.2016150225 · Cited by 49
Management of infective endocarditis and multidisciplinary approach
Camou, F., Dijos, M., Barandon, L., Cornolle, C., Greib, C., Laine, M., Lecomte, R., Boutoille, D., Machelart, I., Peuchant, O., et al. (2018) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2018.06.007 · Cited by 47
Infective endocarditis in children and adolescents: a different profile with clinical implications
Vicent, L., Goenaga, M. Á., Muñóz, P., Marín-Arriaza, M., Valerio, M., Fariñas, M. C., Cobo-Belaustegui, M., de Alarcón, A., Esteban, Á. R., Miró, J. M., et al. (2022) · Pediatric Research · doi:10.1038/s41390-022-01959-3 · Cited by 47
“An increase in Staphylococcus aureus infections has been described,(20) especially in healthcare-related IE cases.(24) In children, both Staphylococcus aureus and Streptococcus spp.”
BackgroundWatson, A., Oh, J. T., Sauve, K., Bradford, P. A., Cassino, C., & Schuch, R. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01078-19 · Cited by 46
Fernández‐Hidalgo, N., Ferreria-González, I., Marsal, J. R., Ribera, A., Aznar, M. L., de Alarcón, A., García-Cabrera, E., Gálvez-Acebal, J., Sánchez-Espín, G., Reguera-Iglesias, J. M., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.019 · Cited by 46
Ortega‐Loubon, C., Muñoz-Moreno, M. F., Garcia, I. A., Alvarez, E., Gómez‐Sánchez, E., Bustamante‐Munguira, J., Lorenzo‐López, M., Tamayo-Velasco, Á., Jorge-Monjas, P., Resino, S., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101755 · Cited by 46
“demonstrated Staphylococcus aureus as the only factor associated with a higher risk of in-hospital mortality in healthcare-associated IE [23].”
BackgroundTristan, A., Rasigade, J., Ruizendaal, E., Laurent, F. J., Bes, M., Meugnier, H., Lina, G., Étienne, J., Célard, M., Tattevin, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051172 · Cited by 45
“aureus could be associated with certain clinical characteristics of the patients, search of associations between CC (assigned by the microarrays) and the patient database of the 2008 survey [6] was performed.”
BackgroundMethodSelf-citationSengupta, S. P., Prendergast, B., Laroche, C., Furnaz, S., Ronderos, R., Almaghraby, A. M., Asch, F. M., Blechova, K., Zaky, H., Strahilevitz, J., et al. (2022) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcac012 · Cited by 45
“001) and presented later (median [IQR) days since symptom onset: Group 1 - 12 [3-35];”
Acute kidney injury in infective endocarditis: A retrospective analysis
Gagneux‐Brunon, A., Pouvaret, A., Maillard, N., Berthelot, P., Lutz, M. F., Cazorla, C., Tulane, C., Fuzellier, J. F., Verhoeven, P. O., Fresard, A., et al. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.03.015 · Cited by 45
Self-citationPseudomonas aeruginosa and Other Pseudomonas Species
D’Agata, E. M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00221-6 · Cited by 44
Teh, W. K., Dramsi, S., Tolker‐Nielsen, T., Yang, L., & Givskov, M. (2019) · Journal of Bacteriology · doi:10.1128/jb.00597-18 · Cited by 44
Prosthetic valve endocarditis due toPropionibacterium acnes
van Valen, R., van Wijngaarden, R. A. F. D. L., Verkaik, N. J., Mokhles, M. M., & Bogers, A. J. J. C. (2016) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivw087 · Cited by 44
Østergaard, L., Smerup, M., Iversen, K. K., Jensen, A. D., Dahl, A., Chamat‐Hedemand, S., Bruun, N. E., Butt, J. H., Bundgaard, H., Torp-Pedersen, C. T., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05422-8 · Cited by 44
Escolà‐Vergé, L., Fernández‐Hidalgo, N., Larrosa, N., Fernandez-Galera, R., & Almirante, B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04117-x · Cited by 44
Failure of Early Diagnosis of Infective Endocarditis in Japan—A Retrospective Descriptive Analysis
Fukuchi, T., Iwata, K., & Ohji, G. (2014) · Medicine · doi:10.1097/md.0000000000000237 · Cited by 44
“Gram-positive cocci, n (%) 70 (85) 34 (97) 36 (77) Streptococci, n (%) 26 (32) 10 (29) 16 (34) viridans Streptococci 15 (18) 7 (20) 8 (17) Abiotrophia, Granulicatella, Gemella 3 (4) 1 (3) 2 (4) S bovis 2 (2) 0 2 (4) S agalactiae 2 (2) 1 (3) 1 (2) Alfa-Streptococci 4 (5) 1 (3) 3 (6) Staphylococcus aureus, n (%) 34 (41)…”
BackgroundInfluentialThe “3M” Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary
Sollini, M., Berchiolli, R. N., Bolton, R. C. D., Rossi, A., Kirienko, M., Boni, R., Lazzeri, E., Slart, R. H. J. A., & Erba, P. A. (2018) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.12.003 · Cited by 43
A review of current treatment strategies for infective endocarditis
Paz, D. L., Lakbar, I., & Tattevin, P. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822165 · Cited by 43
“staphylococci as the primary pathogens responsible for IE, along with the emergence of healthcare-related IE [8,9].”
BackgroundChallenges and Updates in the Diagnosis and Treatment of Infective Endocarditis
Sebastian, S. A., Co, E. L., Mehendale, M., Sudan, S., Manchanda, K., & Khan, S. S. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101267 · Cited by 43
Infective endocarditis in the Lao PDR: Clinical characteristics and outcomes in a developing country
Mirabel, M., Rattanavong, S., Frichitthavong, K., Chu, V., Kesone, P., Thongsith, P., Jouven, X., Fournier, P., Dance, D. A. B., & Newton, P. N. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.184 · Cited by 43
Valenzuela, I. A., Hunter, M. D., Sundheim, K. M., Klein, B., Dunn, L. E., Sorabella, R. A., Han, S. M., Willey, J. Z., George, I., & Gutierrez, J. (2018) · Internal Medicine Journal · doi:10.1111/imj.13958 · Cited by 42
Pericart, L., Fauchier, L., Bourguignon, T., Bernard, L., Angoulvant, D., Delahaye, F., Babuty, D., & Bernard, A. B. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.02.010 · Cited by 42
Self-citationRagnarsson, S., Salto‐Alejandre, S., Ström, A., Olaison, L., & Rasmussen, M. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020221 · Cited by 42
“Severe major mitral insufficiency 194 (23) 149 (19) 90 (17) 0.”
Thirty‐Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database
Morita, Y., Haruna, T., Haruna, Y., Nakane, E., Yamaji, Y., Hayashi, H., Hanyu, M., & Inoko, M. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011598 · Cited by 42
“The most common causes of 30-day readmission were IE, followed by sepsis, congestive heart failure, complications of device and graft, acute renal failure, and acute cerebrovascular disease; these were followed by valvular disease, cardiac arrhythmias, complications of surgical procedures, and pneumonia (Table 3).”
InfluentialUrina-Jassir, M., Jaimes-Reyes, M. A., Martínez-Vernaza, S., Quiroga, C., & Urina‐Triana, M. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.02.022 · Cited by 41
Ásgeirsson, H., Thalme, A., & Weiland, O. (2016) · Medicine · doi:10.1097/md.0000000000005617 · Cited by 41
“[21–24] The high incidence noted in the study is probably in part related to our mainly urban population.”
BackgroundNeuville, M., El-Helali, N., Magalhaes, É., Radjou, A., Smonig, R., Soubirou, J.-F., Voiriot, G., Monnier, A. L., Ruckly, S., Bouadma, L., et al. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0255-8 · Cited by 41
“SOFA score on Day 0 7 [4, 10] 9 [6, 11] 1.”
BackgroundProfile of infective endocarditis observed from 2003 - 2010 in a single center in Italy
Ferraris, L., Milazzo, L., Ricaboni, D., Mazzali, C., Orlando, G., Rizzardini, G., Cicardi, M., Raimondi, F., Tocalli, L., Cialfi, A., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-545 · Cited by 40
Chirouze, C., Patry, I., Duval, X., Baty, V., Tattevin, P., Aparicio, T., Pagenault, M., Carbonnel, F., Couetdic, G., & Hoen, B. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1863-3 · Cited by 39
Self-citationOestergaard, L. B., Schmiegelow, M., Bruun, N. E., Skov, R. L., Petersen, A., Andersen, P. S., & Torp-Pedersen, C. T. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2691-3 · Cited by 39
“Staphylococcus aureus is the leading cause of infective endocarditis in several countries [28, 29], but we did not find SES to be associated with subsequent risk of endocarditis among patients diagnosed with SAB, and the lack of an association did not appear to be caused by a higher mortality rate in individuals with…”
BackgroundPeinado-Acevedo, J. S., Hurtado-Guerra, J. J., Hincapié, C., Abad, J. M., Uribe-Delgado, J. R., Giraldo-Ramírez, S., Lengerke-Diaz, P. A., & Jaimes, F. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1844 · Cited by 38
Hetem, D. J., Rooijakkers, S. H. M., & Ekkelenkamp, M. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00176-3 · Cited by 38
Laabei, M., Jamieson, W. D., Massey, R. C., & Jenkins, A. T. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087270 · Cited by 37
“This organism can cause a wide array of diseases from superficial skin lesions to more serious life-threatening illnesses, being the leading bacterial agent in infective endocarditis [2,3,4].”
BackgroundTokarski, F. V., Lemaignen, A., Portais, A., Fauchier, L., Hennekinne, F., Sautenet, B., Halimi, J., Legras, A., Patat, F., Bourguignon, T., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.08.022 · Cited by 37
Marks, D. J., Hyams, C. J., Koo, C. Y., Pavlou, M., Robbins, J., Koo, C. S., Rodger, G., Huggett, J. F., Yap, J. A., Macrae, M. B., et al. (2014) · QJM · doi:10.1093/qjmed/hcu188 · Cited by 37
Staphylococcal DNA Repair Is Required for Infection
Ha, K. P., Clarke, R. S., Kim, G. L., Brittan, J. L., Rowley, J. E., Mavridou, D. A. I., Parker, D., Clarke, T. B., Nobbs, A. H., & Edwards, A. M. (2020) · mBio · doi:10.1128/mbio.02288-20 · Cited by 36
Donal, E., Tribouilloy, C. M., Sadeghpour, A., Laroche, C., Rodrigues, A. C. T., Nunes, M. C. P., Kang, D., Menêses, M. S. L., Kobalava, Z. D., Bonis, M. D., et al. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead064 · Cited by 36
Aspirin Effect on Staphylococcus aureus—Platelet Interactions During Infectious Endocarditis
Hannachi, N., Habib, G., & Camoin‐Jau, L. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00217 · Cited by 36
Triggers of Inflammatory Heart Disease
Lasrado, N., Yalaka, B., & Reddy, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00192 · Cited by 35
Arora, N., Panda, P. K., Revaiah, P. C., Uppal, L., Saroch, A., Angrup, A., Sharma, N., Sharma, Y. P., Vijayvergiya, R., Rohit, M. K., et al. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.09.008 · Cited by 35
Bartonella Endocarditis in Spain: Case Reports of 21 Cases
García-Álvarez, L., García-García, C., Muñóz, P., Fariñas, M. C., Cuadra, M., Fernández‐Hidalgo, N., García‐Vázquez, E., Moral‐Escudero, E., Alonso‐Socas, M. D. M., García-Rosado, D., et al. (2022) · Pathogens · doi:10.3390/pathogens11050561 · Cited by 35
“7 episodes per 100,000 inhabitants per year [2,3].”
BackgroundStaphylococcus aureus Infections in Children With Congenital Heart Disease
McNeil, J. C., Ligon, J. A., Hultén, K. G., Dreyer, W. J., Heinle, J. S., Mason, E. O., & Kaplan, S. L. (2013) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pit037 · Cited by 35
“In addition, in the United States, S aureus has emerged as the primary cause of IE in adults and children [4–6] and therefore may pose a particular danger to children with CHD.”
BackgroundHost–Bacterium Interaction Mechanisms in Staphylococcus aureus Endocarditis: A Systematic Review
Nappi, F., & Singh, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311068 · Cited by 34
Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals
Damasco, P. V., Ramos, J. N., Correal, J. C. D., Pötsch, M., Vieira, V. V., Camello, T. C. F., Pereira, M. P., Marques, V. D., dos Santos, K. R. N., Marques, E. A., et al. (2014) · Infection · doi:10.1007/s15010-014-0640-2 · Cited by 34
“In the contemporary population-based studies of IE in industrialized countries, in-hospital mortality ranges from 15 to 22 % increased healthcare-associated infections and less rheumatic heart disease as risk factors [24, 25].”
BackgroundYen, C., Wang, C.-K., Chen, S.-Y., Gao, S.-Y., Lo, H.-Y., Ng, C., & Chaou, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-00897-0 · Cited by 34
Infective endocarditis: Surgical management and prognostic predictors
Moreira, R. I., Cruz, M. C., Branco, L. M., Galrinho, A., Miranda, L. C., Fragata, J., & Ferreira, R. C. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.08.007 · Cited by 33
Lemaignen, A., Bernard, L., Tattevin, P., Bru, J. P., Duval, X., Hoen, B., Brunet-Houdard, S., Mainardi, J., & Caille, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033540 · Cited by 33
Self-citationLong-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis
Abdallah, L., Rémadi, J. P., Habib, G., Salaün, E., Casalta, J., & Tribouilloy, C. M. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.11.012 · Cited by 32
Lecomte, R., Bourreau, A., Deschanvres, C., Issa, N., Turnier, P. L., Gaborit, B. J., Chauveau, M., Leroy, A., Tourneau, T. L., Caillon, J., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.08.044 · Cited by 32
Kim, K., Kim, D., Lee, S., Cho, I. J., Shim, C. Y., Hong, G., & Ha, J. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0609 · Cited by 32
Surgical treatment of transcatheter aortic valve infective endocarditis
Malvindi, P. G., Luthra, S., Sarvananthan, S., Zingale, A., Olevano, C., & Ohri, S. K. (2020) · Netherlands Heart Journal · doi:10.1007/s12471-020-01494-y · Cited by 32
International guideline changes and the incidence of infective endocarditis: a systematic review
Khan, O., Shafì, A. M. A., & Timmis, A. (2016) · Open Heart · doi:10.1136/openhrt-2016-000498 · Cited by 32
Oberbach, A., Schlichting, N. S., Feder, S., Lehmann, S., Kullnick, Y., Buschmann, T., Blumert, C., Horn, F., Neuhaus, J., Neujahr, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175569 · Cited by 32
Oral hygiene and infective endocarditis: a case control study
Lockhart, P. B., Chu, V. H. Y., Zhao, J., Gohs, F. X., Thornhill, M. H., Pihlstrom, B. L., Mougeot, F. B., Rose, G. A., Sun, Y., Napeñas, J. J., et al. (2023) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2023.02.020 · Cited by 32
Prosthetic valve endocarditis: state of the heart
Nagpal, A., Sohail, M. R., & Steckelberg, J. M. (2012) · Clinical Investigation · doi:10.4155/cli.12.70 · Cited by 31
Goehringer, F., Lalloué, B., Selton‐Suty, C., Alla, F., Botelho-Nevers, É., Chirouze, C., Curlier, E., Hatimi, S. E., Gagneux‐Brunon, A., Moing, V. L., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae035 · Cited by 31
Self-citationBelletti, A., Jacobs, S., Affronti, G., Mladenow, A., Landoni, G., Falk, V., & Schoenrath, F. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.12.015 · Cited by 30
Lecomte, R., Issa, N., Gaborit, B. J., Turnier, P. L., Deschanvres, C., Asseray, N., Tourneau, T. L., Michel, M., Habash, O. A., Bizouarn, P., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz014 · Cited by 30
Clinical Features and Outcome of Infective Endocarditis in a University Hospital in Romania
Babeş, E. E., Lucuța, D. A., Petcheși, C. D., Zaha, A. A., Ilyes, C., Jurcă, A. D., Vesa, C. M., Zaha, D. C., & Babeş, V. V. (2021) · Medicina · doi:10.3390/medicina57020158 · Cited by 30
SPILF update on bacterial arthritis in adults and children
Stahl, J. ‐., Canouï, É., Pavèse, P., Bleibtreu, A., Dubée, V., Ferry, T., Gillet, Y., Lemaignen, A., Lorrot, M., Lourtet-Hascoët, J., et al. (2023) · Infectious Diseases Now · doi:10.1016/j.idnow.2023.104694 · Cited by 30
Bourque, J. M., Birgersdotter-Green, U. M., Bravo, P. E., Budde, R. P. J., Chen, W., Chu, V. H. Y., Dilsizian, V., Erba, P. A., Kattan, C. M. G., Habib, G., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae046 · Cited by 30
Prospective Comparison of Infective Endocarditis in Khon Kaen, Thailand and Rennes, France
Watt, G., Lacroix, A., Pachirat, O., Baggett, H. C., Raoult, D., Fournier, P., & Tattevin, P. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0689 · Cited by 30
Complications et pronostic de l’endocardite infectieuse
Selton‐Suty, C., Goehringer, F., Venner, C., Thivilier, C., Huttin, O., & Hoen, B. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.04.002 · Cited by 30
Self-citationPrognostic nutritional index predicts mortality in infective endocarditis
Kahraman, S., Ağuş, H. Z., Kalkan, A. K., Uzun, F., Ertürk, M., Kalkan, M. E., & Yıldız, M. (2020) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2020.25899 · Cited by 30
Characteristics of infective endocarditis in a cancer population
Grable, C., Yusuf, S. W., Song, J., Viola, G. M., Ulhaq, O., Banchs, J. A., Jensen, C. T., Goel, H., & Hassan, S. A. (2021) · Open Heart · doi:10.1136/openhrt-2021-001664 · Cited by 29
Characteristics and prognosis of pneumococcal endocarditis: a case–control study
Daudin, M., Tattevin, P., Lelong, B., Flecher, E. M., Lavoué, S., Piau, C., Ingels, A., Chapron, A., Daubert, J., & Revest, M. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.03.011 · Cited by 29
“Streptococcus pneumoniae, responsible for <1% of IE [2], has also been associated with rapidly progressive IE, extensive valvular destruction, heart failure and high lethality, in case reports or series published >10 years ago [4–6], but no comparative study has been performed between pneumococcal endocarditis (PE) an…”
BackgroundSelf-citationAhtela, E., Oksi, J., Vahlberg, T. J., Sipilä, J., Rautava, P. T., & Kytö, V. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254553 · Cited by 29
“Previous studies have reported similar short-term [5,10,11] and longer-term mortality [9,12,13] in women compared to men.”
BackgroundResultInfluentialCrepin, D. M., Chavignon, M., Verhoeven, P. O., Laurent, F. J., Josse, J., & Butin, M. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00118-23 · Cited by 28
Tran, H. M., Truong, V. T., Ngo, T. M. N., Bui, Q. P. V., Nguyen, H. C. B., Le, T. T. Q., Mazur, W. M., Chung, E. S., Cafardi, J. M., Pham, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189421 · Cited by 28
Sousa, C., Nogueira, P., & Pinto, F. J. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01937-3 · Cited by 27
Risk for infective endocarditis in bacteremia with Gram positive cocci
Andersen, M. H., Holle, S. L. D., Klein, C. F., Bruun, N. E., Arpi, M., Bundgaard, H., Tønder, N., & Iversen, K. K. (2020) · Infection · doi:10.1007/s15010-020-01504-6 · Cited by 27
“Previous studies have shown that 79–90% of all cases of IE are caused by Gram positive cocci [3, 5, 6].”
ResultNarui, R., Nakajima, I., Norton, C. A., Holmes, B. B., Yoneda, Z. T., Phillips, N., Schaffer, A. J., Tinianow, A. M., Aboud, A. A., Stevenson, W. G., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.01.010 · Cited by 27
Bellouard, R., Deschanvres, C., Deslandes, G., Dailly, É., Asseray, N., Jolliet, P., Boutoille, D., Gaborit, B. J., & Grégoire, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00806-19 · Cited by 26
Bourque, J. M., Birgersdotter-Green, U. M., Bravo, P. E., Budde, R. P. J., Chen, W., Chu, V. H. Y., Dilsizian, V., Erba, P. A., Kattan, C. M. G., Habib, G., et al. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.01.004 · Cited by 26
Bouchiat, C., Ginévra, C., Benito, Y., Gaillard, T., Salord, H., Dauwalder, O., Laurent, F. J., & Vandenesch, F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.943441 · Cited by 26
“Bacterial identifications were consistent with well-known aetiologies (Plainvert et al., 2012; Selton-Suty et al., 2012; Vieira et al., 2015; Dyrhovden et al., 2019) but also scarcely”
BackgroundMethodSelf-citationDamlin, A., Westling, K., Maret, E., Lundborg, C. S., Caidahl, K., & Eriksson, M. J. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4682-z · Cited by 25
Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019*
Yavuz, S. Ş., Akar, A. R., Aydoğdu, S., Deniz, D. B., Demir, H., Hazırolan, T., Ozatik, M. A., Özer, N., Sargın, M., Topçuoğlu, N., et al. (2020) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2020.89689 · Cited by 25
Weymann, A., Konertz, J., Laule, M., Stangl, K., & Dohmen, P. M. (2017) · Medical Science Monitor · doi:10.12659/msm.902785 · Cited by 25
Benedetto, U., Spadaccio, C., Gentile, F., Moon, M. R., & Nappi, F. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3880 · Cited by 25
“S aureus is the most frequently isolated pathogen in infectious endocarditis in high-income countries with a reported percentage of 30% of cases (29,30).”
BackgroundUrien, J.-M., Camus, C., Leclercq, C., Dejoies, L., Mabo, P., Martins, R. P., Boukthir, S., Bénézit, F., Béhar, N., Revest, M., et al. (2021) · Infection · doi:10.1007/s15010-021-01634-5 · Cited by 25
Self-citationTrifunović, D., Vujisic-Tesic, B. D., Obrenović-Kirćanski, B., Ivanović, B., Kalimanovska‐Oštrić, D., Petrović, M., Boricic-Kostic, M., Matic, S., Stevanović, G., Marinković, J., et al. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.08.010 · Cited by 25
Abdallah, L., Habib, G., Rémadi, J. P., Salaün, E., Casalta, J., & Tribouilloy, C. M. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.02.010 · Cited by 25
Tagliari, A. P., Steckert, G. V., da Silveira, L. M. V., Kochi, A. N., & Wender, O. C. B. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14787 · Cited by 24
Molecular Targets for Antibody-Based Anti-Biofilm Therapy in Infective Endocarditis
Han, J., & Poma, A. (2022) · Polymers · doi:10.3390/polym14153198 · Cited by 24
Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented
Benito, N., Pericàs, J. M., Gurguí, M., Mestres, C. A., Marco, F., Moreno, A., Horcajada, J. P., & Miró, J. M. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0439-4 · Cited by 24
“In recent studies, in-hospital mortality ranged between 15 and 22 %, although rates across patient subgroups vary considerably [2, 7].”
Infective Endocarditis in the Intensive Care Unit
Keynan, Y., Singal, R. K., Kumar, K., Arora, R. C., & Rubinstein, E. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.06.011 · Cited by 24
Metadata
- Authors
- Selton-Suty, C., Célard, M., Le Moing, V., Doco-Lecompte, T., Chirouze, C., Iung, B., Strady, C., Revest, M., Vandenesch, F., Bouvet, A., Delahaye, F., Alla, F., Duval, X., & Hoen, B.
- Affiliations
- Laboratoire Chrono-Environnement (FR)
- Hôpital Pontchaillou (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-01
- Volume
- 54
- Issue
- 9
- Pages
- 1230-1239
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2155794989
- Semantic Scholar
- 46e2ed77823a43f31fbb6342dfb12aabb30be85d
- Cited by
- 710
- References
- 29
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 55 · 2023: 66 · 2022: 64 · 2021: 51 · 2020: 65 · 2019: 67 · 2018: 42 · 2017: 53 · 2016: 56 · 2015: 47 · 2014: 32 · 2013: 35 · 2012: 8
- FWCI
- 29.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- infective endocarditis, Staphylococcus aureus, coagulase-negative staphylococci, community-acquired endocarditis, incidence, in-hospital mortality, risk factors, referral bias
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cross Infection, Endocarditis, Bacterial, Female, France, Hospitals, Humans, Male, Middle Aged, Population Surveillance, Prognosis, Risk Factors, Staphylococcal Infections, Staphylococcus, Staphylococcus aureus, Incidence, Community-Acquired Infections, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.